This is an observational COVID-19 study that uses wearable health monitoring technology to follow COVID-19 positive individuals to monitor persistent symptoms and any potential long-term complications or cardiovascular and behavioral impacts from the disease.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Incidence of major cardiovascular events
Timeframe: 12 Months
Incidence of atrial arrhythmia
Timeframe: 12 Months
Mental health effect of COVID-19 measured by incidence of Generalized Anxiety Disorder (GAD) using Generalized Anxiety Disorder 7-item (GAD-7) Scale
Timeframe: 12 Months
Mental health effect of COVID-19 measured by incidence of depression using Beck Depression Fast Screen Scale
Timeframe: 12 Months
Mental health effect of COVID-19 measured by incidence of Post Traumatic Stress Syndrome (PTSD) using the Post Traumatic Stress Disorder Checklist- Standard Form (PCL-S) scale
Timeframe: 12 Months
Mental health effect of COVID-19 measured by incidence of substance abuse using a baseline use of alcohol survey
Timeframe: 12 Months
Mental health effect of COVID-19 measured by incidence of substance abuse using a baseline use of drugs survey
Timeframe: 12 Months
Mental health effect of COVID-19 measured by incidence of substance abuse using a baseline use of nicotine products survey
Timeframe: 12 Months